Rip biological, as our animal health products industry leader, a focus on China A share market listed companies in the field of veterinary medicine, biotechnology and animal aiming at the international forefront of medical development around the needs of sustainable agricultural development in the country, adhering to the "forward-looking, innovation, integrity, sharing" business philosophy, with high quality, high performance products are the industry advances in technology, aquaculture development and health security contributions of food of animal origin of power.

Rip Biology was established in 1998, the venture more than a decade, innovative, pioneering spirit, the first single from the large scale business growth as the animal health industry cluster. Owns Rip (Tianjin) Biotechnology Pharmaceutical Co., Ltd., Rip (Baoding) Bio-Pharmaceutical Co., Ltd., Tianjin Hi-Tech Bio-Pharmaceutical Co., Rip, Lung, Hubei Pharmaceutical Co., Ltd. (shares), bio-medicine, Hunan shore Co., Ltd. (shares), 内蒙古瑞普 land animals Pharmaceutical Co., Ltd. (shares) 6 GMP production bases, with raw material drug production line, powder/powder/premix, oral production, disinfectant production lines, injection lines, grain agent production line, tablet production, inactivated vaccine production lines, live vaccine production lines, and 30 large-scale production line, with great production capacity of China's collection of biological vaccines, pharmaceutical raw materials, pharmaceutical preparations, feed additives, four in one of China's largest product range most all the production bases of animal health products.

Rip committed to continuous development and production of high quality and high value-added products. Currently has poultry, livestock, pets, aquatic animals, 280 kinds of products, including nearly 170 kinds of chemical drugs, biological products, 50 kinds, 30 kinds of feed additives, 30 kinds of plant extract preparations. Product is character, integrity control, quality of life, Rip keep quality commitment to adhere to internal control standards 10%higher than the national standards, product quality sampling rate of qualified forefront of the industry for 11 years, the main products in multiple market segments among the best. Good market share and the effect of high-quality products, so that "Rip" brand won the industry and widely recognized by customers, by the National Association as "veterinary biologics 10 companies," "top 30 veterinary pharmaceutical preparations enterprise ", Rip products were identified as" Tianjin Famous Brand "," Rip "trademark has been selected as" China's animal health industry's most influential brand in 2006 "," 2009 Influential Brand of animal husbandry "," Memorial 30 years of reform and opening up the national livestock industry's most influential brand. " Rip creature with great scientific and technological innovation, to become "China Animal Husbandry and Veterinary science and technology innovation leader." Lead the market with innovative products, excellent quality to win the market, based on Rip-end, committed to innovation, promoting the sustainable and healthy development of animal health industry.

Rip has been established in 30 provinces nationwide distribution facilities in 21 provinces in government procurement tenders awarded, with 743 large-scale farming enterprises to establish a stable partnership. A distribution customers of more than 2200, covering the country's 500 key farming counties. Has started to Egypt, Jordan, Pakistan, Philippines and other countries for product registration and sales. The perfect market network construction, fast and efficient logistics service mechanism, integrated marketing, to provide customers with "one stop" full service.

Rip biological, animal health industry leader in China's flagship! Pharmaceutical Pioneer, trust lies.